Harvard Business Review

JANUARY 25, 2012

I learned the critical importance of networking, and discovered my natural aversion to it, early in my career. That night, because of the small turnout, I had the pleasure and advantage of engaging in one-on-one conversations with some of the company's top executives, an experience that would prove crucially important in advancing my career.

Pharmaceuticals 19

Pharmaceuticals Conference Learning-by-Doing Strategic Planning 19

The Practical Leader

APRIL 6, 2022

Many more people are searching beyond a job or career to find a calling. ” These shifts have profound implications for leadership and culture. ” Pharmaceutical company: “ Preserving and improving human life.” Creating leadership energy is an inside job. We want to make a difference.

Mintzberg 111

Mintzberg Pharmaceuticals Energy McKinsey 111

Harvard Business Review

FEBRUARY 21, 2012

Having a strong domestic manufacturing base is vital to the United States maintaining its world leadership in innovation. Since joining the Harvard Business School in 2007 (after a long career at IBM, Kodak, Silicon Graphics, and other companies), I have visited hundreds of factories.

Supply Chain 15

Supply Chain Offshoring Engineering Pharmaceuticals 15

Harvard Business Review

OCTOBER 29, 2013

When he questioned the mine leadership team he was told, “We’ve heard this story before but we produce too much ore for the company to really shut us down.”. Despite not having sufficient new products to replace these losses, the team delayed making commensurate cost reductions, with each manager saying that their people were indispensable.

Pharmaceuticals 12

Pharmaceuticals Discount Learning-by-Doing Team 12

Harvard Business Review

DECEMBER 27, 2016

Doctors were once viewed as ill-prepared for leadership roles because their selection and training led them to become “heroic lone healers.” The emphasis on patient-centered care and efficiency in the delivery of clinical outcomes means that physicians are now being prepared for leadership. ” But this is changing.

Management 15

Management 360-Degree Feedback Mayo Training 15

Harvard Business Review

NOVEMBER 9, 2011

COOs are relatively common in service industries such as financial services, energy, information technology and telecommunications, but in manufacturing sectors — such as automotive, chemical, and pharmaceutical companies — they are relatively rare. It still doesn't seem necessary to be a COO in order to take over as CEO, though.

COO 12

COO Sample Telecommunications Automotive 12

Harvard Business Review

MARCH 24, 2017

Compensation should be tied to broad-based outcomes and include things such as customer satisfaction and product knowledge, in addition to success at closing deals. These practices continued under executive leadership that stifled disagreement with superiors and, all told, led to $1.2 If there is a disconnect, that is a red flag.

Ethics 8

Ethics Company Incentives Policies 8

Harvard Business Review

NOVEMBER 1, 2018

On average, one of them will be sexually harassed during the next 4 years, before she has even begun her career as a physician’ ” The efforts of many healthcare organizations and medical centers tend to go little further than avoiding litigation. Leadership. This needs to change.

Health Care 8

Health Care Policies How To Reputation 8

Harvard Business Review

JULY 7, 2011

It's amazing how much one troubled employee can undermine a department's productivity. Otherwise positive and productive team members begin to dread coming to work, and the group's best thinking gets siphoned off the company's mission as everyone scrambles to stay out of the bully's crosshairs.

Rogers 14

Rogers Morale Long-term Pharmaceuticals 14

Harvard Business Review

MAY 10, 2018

Black women continue to be sorely underrepresented in leadership roles in corporate America. We sought to understand the barriers they faced, their strategies for ascending through the organization, and the tools they used to manage significant organizational change efforts and navigate career risks. Currently, they make up 12.7%

Execution 11

Execution Strategy Self-aware Career 11

Harvard Business Review

SEPTEMBER 4, 2015

However, CEOs often don’t have the career background and education that would equip them to personally lead the process of new product development. We found that, for pharmaceutical industry CEOs, there is a statistically significant relationship between a CEO’s specialist background and the firm’s performance.

CEO 8

CEO Innovation Pharmaceuticals Merchandising 8

Harvard Business Review

APRIL 19, 2016

Those factors do play important roles, but the most important thing driving America’s success has been its unparalleled scientific leadership. So for companies looking to create revolutionary products, identifying and accessing cutting edge, exploratory research is a key competitive advantage.

Innovation 8

Innovation Company Competitive Advantage Venture Funding 8

Harvard Business Review

OCTOBER 11, 2013

Much as I want to believe that a glaringly good idea will stand on its merits, I have come to realize that just like any product or service, ideas require good marketing if they’re going to reach their intended customers. Celine Schillinger sought to change the leadership landscape of Sanofi, a major pharmaceutical company.

Innovation 11

Innovation Christensen Decisionmaking CTO 11

Harvard Business Review

NOVEMBER 7, 2012

R&D investments have been made, stage/gate processes have been built, creativity training courses have been run, and yet the outputs — exciting new products and services — don't seem to be falling into place. So what to do? Tolerance of Failure. It is axiomatic that successful innovation requires tolerance of failure.

Company 8

Company Stage-Gate Innovation Bureaucracy 8

Harvard Business Review

MAY 17, 2016

He had started his career in one of those jobs, as a country manager, and worked his way up. The key product and customer jobs no longer attracted the best talent. Distortion of decisions: A number of years ago we studied in detail how the most important decisions like product approvals were made at a large pharmaceutical firm.

Execution 10

Execution Bureaucracy Self-aware CEO 10